Consumer Counsel Gets $115M From EpiPen Settlement
A Kansas federal judge granted final approval to the $345 million settlement between Pfizer and the consumer classes that accused it of scheming to inflate the price of its emergency allergy...To view the full article, register now.
Already a subscriber? Click here to view full article